Specialty Pharmaceutical Company dedicated to patients living with chronic pain

« Back

Document Details

Form
Filing Date
Jan 18, 2019
Document Date
Jan 15, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
BioDelivery Sciences International, Inc.
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Thank you. We will get back to you soon